Reliable Transportation Isn’t a Luxury — It’s an Important Part of Cancer Care
Insecurity about transportation can lead to missed appointments and delayed care, and obstacles are more common for cancer patients than for the general population.
Making Exercise a Standard in Cancer Survivorship Care
We know that exercise is medicine. The science is clear, the mechanisms are known, and the tools are available to deliver it safely. To make all that mean something for patients, cancer care must evolve to include movement as a standard element of every stage of the journey, not as a wellness option, but as a clinical necessity.
presented by
The Healthcare Payments Industry Has a Perception Problem
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment
If we truly believe in treating the whole patient, we must recognize that survival is not the only measure of success. Preserving a woman’s sense of self, her dignity, her identity, her autonomy is just as essential.
Unlocking the Future of Radioligand Therapy: From Discovery to Delivering at Scale
As radiopharmaceuticals enter a new phase, industry leaders must rethink external services and internal capabilities to master the complexities of delivering advanced therapies.
What We’re Still Getting Wrong in Cancer Care — Glaring Gaps in the Face of Astonishing Advancements
Amidst the distress caused by a cancer diagnosis, patients are left to sort through vast amounts of information, treatment options, and concerns around efficacy and side effects, while juggling other life activities.
MedCity Pivot Podcast: How AI Can Help in Cancer
Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera's chief medical officer and the company has built a digital pathology tool for prostate cancer patients.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance
Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own diagnostic data to define the extent of the disease and create a cancer probability map with optimal treatment margins.
5 years after FDA approval, CAR-T treatment looks like the future of medicine
CAR-T has become increasingly recognized as an exciting and potentially paradigm-shifting treatment in the past five years. In fact, more than 10,000 patients have undergone this new treatment for certain types of leukemia, lymphoma and multiple myeloma.
Are metabolic hormones the next frontier in cancer treatment?
With a global epidemic of obesity and diabetes and their known relationship to cancer, researchers and oncologists are turning their attention to metabolic hormones as promising new targets for cancer treatment.
Don’t miss this innovation in cancer treatment conference in Philadelphia
The MedCity CONVERGE conference at the University City Science Center June 19 in Philadelphia will be the scene of a dynamic series of conversations around cancer treatment, precision medicine, value-based care and investment trends. It will spotlight industry experts, presentations from innovative startups and collaborations.
presented by
New Webinar: The Payer AI Readiness Gap: Why Better Data Will Define the Next Era of Health Plan Performance
We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.
Wireless injectable computer could deliver more accurate reading of tumor pressure
Engineering researchers at the University of Michigan have developed a battery-operated injectable computer with a radio antenna that can transmit data to a device located up to 12 inches outside of the body.
Will CAR-T deliver on the promise of widespread therapeutic improvement?
So where are we with CAR-T? Is it the innovative, transformative, disruptive, paradigm-changing cancer therapy we all hope for, or is it another incremental improvement?
ASCO: Newly approved drug for renal cell carcinoma lowers death rate
Patients with previously treated advanced renal cell carcinoma have a new treatment option with cabozantinib — a kinase inhibitor shown to improve overall survival compared to everolimus, as a Cleveland Clinic researcher noted at ASCO 2016 over the weekend.
Gilead Sciences holding off on six trials for its cancer drug Zydelig due to concerns of adverse effects and deaths
The FDA issued an alert about the drug on Monday, and in the warning it warned healthcare professionals that the drug is not approved for previously untreated chronic lymphocytic leukemia.
Health IT company raises $1.2M to advance predictive analytics tool for radiation therapy
Oncora Medical's approach provides clinical decision support for radiation oncologists to reduce radiation toxicity and guide more personalized treatments.